Crossmark

Molecules interacting with CasL-Like 2 enhances tumor angiogenesis and progression by activating mTOR/HIF1α/VEGF pathway in kidney renal clear cell carcinoma

Crossref DOI link: https://doi.org/10.1038/s41598-025-20400-3

Published Online: 2025-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Song, Yuxin

Zhang, Jiajun

Liu, Guocheng

Jiang, Xiaoxiao

Sun, Ningchuan

He, Han

Song, Shu

Wang, Wei
Funding

Funding for this research was provided by:

Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University ((PY2023023))

Medical Research Project by the Jiangsu Commission of Health ((H2023095))
License Information

Text and Data Mining valid from 2025-10-21

Version of Record valid from 2025-10-21
More Information

Article History

Received: 16 May 2025

Accepted: 15 September 2025

First Online: 21 October 2025

Declarations

:

: This study was approved by the Ethics Review Committee of Yancheng NO.1 People’s Hospital, and all samples were obtained from the hospital’s biobank. Ethical approval number: 2024-K-361.

: All authors have read and approved the final manuscript and consent to its publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below